Andrea DiFabio's most recent trade in Xenon Pharmaceuticals Inc was a trade of 80,000 Share Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 9, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Xenon Pharma Inc | Andrea DiFabio | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2026 | 80,000 | 80,000 | - | - | Share Option (Right to Buy) | |
| Xenon Pharma Inc | Andrea DiFabio | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2026 | 15,000 | 15,000 | - | - | Restricted Share Units | |
| Xenon Pharma Inc | Andrea DiFabio | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 80,000 | 80,000 | - | - | Share Option (Right to Buy) | |
| Xenon Pharma Inc | Andrea DiFabio | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 15,000 | 15,000 | - | - | Restricted Share Units | |
| Xenon Pharma Inc | Andrea DiFabio | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Xenon Pharma Inc | Andrea DiFabio | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2023 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) |